Limited coverage criteria – fosinopril (ACE inhibitor)

Last updated on March 18, 2025

 

Return to Special Authority drug list 

Generic name

fosinopril                        

Strength & form

10 mg, 20 mg tablet

Special Authority criteria

Approval period

Treatment failure on optimal doses of, or intolerance to, ramipril

OR

Complex patient requiring medications for co-existing chronic condition(s)

Indefinite

Practitioner exemptions

Practitioners in the following specialty are not required to submit a Special Authority request form for coverage:

  • Pediatric
  • Pediatrics cardiology

Special notes

  • Patients with co-existing chronic conditions requiring use of multiple medications will be considered complex for the purposes of Special Authority criteria

Special Authority request form(s)